Skip to main content
Equibles

Key Financial Inc

Position in AXSM — Axsome Therapeutics, Inc.

CIK 1801720 WEST CHESTER, PA
Back to AXSM Full portfolio

Position in AXSM

as of Jun 30, 2026 · filed Jul 24, 2026
Position Value
$110,146
+$34,087 QoQ
Shares Held
450
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#422
of 504 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in AXSM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Key Financial Inc holds $653,965 across 24 Biotechnology names. AXSM ranks #3 (16.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 290 $144,051
2 REGN
Regeneron Pharmaceuticals, Inc.
 210 $130,943
3 AXSM
Axsome Therapeutics, Inc.
This page 		450 $110,146
4 TGTX
Tg Therapeutics, Inc.
 2,000 $109,880
5 KRYS
Krystal Biotech, Inc.
 151 $56,122
6 PGEN
Precigen, Inc.
 5,000 $28,500
7 SRPT
Sarepta Therapeutics, Inc.
 1,050 $18,868
8 IBRX
ImmunityBio, Inc.
 2,000 $17,510

All Filings in AXSM

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $110,146 450
2026-03-31 $76,059 450
2025-12-31 $82,188 450
2025-09-30 $54,652 450
2025-06-30 $46,975 450
2025-03-31 $52,483 450
2024-12-31 $38,074 450
2024-09-30 $40,441 450
2024-06-30 $36,225 450
2024-03-31 $35,910 450
2023-12-31 $35,815 450
2023-09-30 $31,450 450
2023-06-30 $32,337 450
2023-03-31 $27,756 450
2022-12-31 $34,708 450
2022-09-30 $20,079 450
2022-06-30 $17,235 450
2022-03-31 $18,625 450
2021-12-31 $17,001 450
2021-09-30 $47,792 1,450